First-in-human study underway evaluating anti-CD36 monoclonal antibody designed to restore metabolic fitness in exhausted T cells, reduce immunosuppressive cells, and enhance antitumor immunity Pilatu ...

HIIIX recognized for its 3-Year and 10-Year risk-adjusted performance in the High Yield Funds Category (which contains 94 and 84 funds, respectively, as of 11/30/25) ...

BG Staffing Realigns Go-to-Market Strategy to Drive Greater Clarity and Effectiveness PLANO, TX / ACCESS Newswire / ...

At this time, I would like to welcome everyone to the Pangaea Logistics Solutions Fourth Quarter and Full Year 2025 Results Conference Call. Today's call is being recorded and will be available for ...

Immunome is advancing varegacestat for desmoid tumors, targeting NDA submission in Q2 2026 after positive phase 3 RINGSIDE ...

FY25 EPS of $0.08; FY25 Adjusted EPS growth of 5% to $0.83 YoY Increase in Cash Flow from Operations of $148 million; Free ...

The Central Board of Secondary Education (CBSE) conducted the Class 12 Mathematics exam on Monday (March 9). The exam was held from 10.30 am to 1.30 pm for CBSE students across India. Students and ...

Check out the CBSE Class 12 Mathematics question paper 2026 in full here. Students who appeared for the board exam can review the complete paper to analyse section-wise questions, internal choices, ...

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2025 Earnings Call Transcript March 5, 2026 REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.3 EPS, expectations were $-1.01. Operator: Thank you for ...